All articles by Swagath Bandhakavi

Aurion Biotech’s AURN001 gets BTD and RMAT designations from FDA

Its breakthrough therapy and regenerative medicine advanced therapy designations follow the completion of enrolment and dosing in the CLARA Phase 1/2 clinical trial across sites in the US and Canada